Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)
NOTIFY-ASCVD
1 other identifier
interventional
233
1 country
1
Brief Summary
Estimate the impact of notifying both patients and their clinicians of the presence of incidental coronary artery calcium (CAC) on initiation of lipid-lowering therapy in patients with ASCVD who are not receiving lipid-lowering therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2023
CompletedFirst Posted
Study publicly available on registry
May 15, 2023
CompletedStudy Start
First participant enrolled
October 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 24, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 24, 2026
CompletedApril 22, 2026
April 1, 2026
1.4 years
May 5, 2023
April 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Initiation of lipid-lowering therapy
Number of patients who had initiation of lipid-lowering therapy
Month 6
Study Arms (3)
Notification with a CAC image
EXPERIMENTALNotification of presence of CAC with a CT scan image and the ACC/AHA guideline recommendation for initiation of lipid-lowering therapy.
Notification without a CAC image
EXPERIMENTALNotification of presence of CAC without a CT scan image and the ACC/AHA guideline recommendation for initiation of lipid-lowering therapy.
Usual care
NO INTERVENTIONThe usual care arm will not receive any additional notification beyond the standard of care. If the intervention is successful, we will notify patients in the usual care arm of the presence of CAC and the ACC/AHA guideline recommendation for initiation of lipid-lowering therapy.
Interventions
Notification Patients randomized to notification will receive a message sent by either the electronic health record (EHR) patient portal or US mail that will inform them of the CAC identified on their previous chest CT scan (with or without an image) and a recommendation that they discuss this finding and initiation of lipid-lowering therapy with their clinician. The clinicians will be notified of these findings by an earlier EHR message that will be sent 2 weeks before the patient notification. Two months after the initial notification, patients and their clinicians who are randomized to notification arms will receive a second message similar to the initial notification.
Eligibility Criteria
You may qualify if:
- Presence of CAC on non-gated chest CT scans performed from 2021 to 2025
- Age \<85 years
- Diagnosis of ASCVD(coronary artery disease, peripheral artery disease, or cerebrovascular disease)
- Visit to Stanford affiliated clinician since 2022 at one of the following Stanford clinics including University affiliated clinics:
- Internal Medicine
- Family Medicine
- Cardiology
- Neurology
- Vascular surgery
- Primary language is English or Spanish
You may not qualify if:
- No diagnosis of ASCVD
- Patients receiving lipid-lowering therapy
- Dementia
- Metastatic cancer or active cancer undergoing chemotherapy
- Hospice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University
Stanford, California, 94304, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- In the usual care arm, patients or clinicians will not be notified.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine (Cardiovascular Medicine)
Study Record Dates
First Submitted
May 5, 2023
First Posted
May 15, 2023
Study Start
October 22, 2024
Primary Completion
March 24, 2026
Study Completion
March 24, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share